A new study sheds light on why promising cancer treatments can produce dramatically different results across patients.
With promise to slow aging and cure some types of cancer, a new gene therapy presents cost and access hurdles for CT patients ...
According to ImmunityBio, the company that developed Anktiva, the treatment harnesses the body’s immune system to destroy cancer tumors, which could make chemotherapy obsolete. While it received FDA ...
Dr. Bishop shared a Nobel Prize with Harold Varmus for his work on cancer-causing genes called oncogenes. He later served as ...
Image generated by Thyme Care. Opinions expressed by Digital Journal contributors are their own. Social work is often misunderstood in cancer care, yet evidence shows early, proactive support can ease ...
Mike Francisco was an athletic 35-year-old Phoenix medical professional when he was diagnosed with late-stage colon cancer. His story is not unusual.
The very first patient would receive the first clinical doses of HMBD-001, the first cancer treatment from Hummingbird Bioscience. Piers Ingram, the cofounder and CEO of the company, was nervous, but ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results